These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 15458956

  • 1. Prognostic laboratory markers of joint damage in rheumatoid arthritis.
    Lindqvist E, Eberhardt K, Bendtzen K, Heinegård D, Saxne T.
    Ann Rheum Dis; 2005 Feb; 64(2):196-201. PubMed ID: 15458956
    [Abstract] [Full Text] [Related]

  • 2. Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.
    Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S.
    Ann Rheum Dis; 2006 Apr; 65(4):453-8. PubMed ID: 16176994
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Association of anticyclic citrullinated peptide antibodies and/or rheumatoid factor status and clinical presentation in early arthritis: results from the ESPOIR cohort.
    Mouterde G, Lukas C, Goupille P, Flipo RM, Rincheval N, Daurès JP, Combe B.
    J Rheumatol; 2014 Aug; 41(8):1614-22. PubMed ID: 25028372
    [Abstract] [Full Text] [Related]

  • 9. Prognostic factors of radiological damage in rheumatoid arthritis: a 10-year retrospective study.
    Markatseli TE, Voulgari PV, Alamanos Y, Drosos AA.
    J Rheumatol; 2011 Jan; 38(1):44-52. PubMed ID: 20952476
    [Abstract] [Full Text] [Related]

  • 10. Low serum level of COMP, a cartilage turnover marker, predicts rapid and high ACR70 response to adalimumab therapy in rheumatoid arthritis.
    Morozzi G, Fabbroni M, Bellisai F, Cucini S, Simpatico A, Galeazzi M.
    Clin Rheumatol; 2007 Aug; 26(8):1335-8. PubMed ID: 17285224
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Diagnostic impact of contemporary biomarker assays for rheumatoid arthritis.
    Nikolaisen C, Rekvig OP, Nossent HC.
    Scand J Rheumatol; 2007 Aug; 36(2):97-100. PubMed ID: 17476614
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis.
    Lee DM, Phillips R, Hagan EM, Chibnik LB, Costenbader KH, Schur PH.
    Ann Rheum Dis; 2009 Feb; 68(2):201-8. PubMed ID: 18390910
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The presence of rheumatoid nodules at early rheumatoid arthritis diagnosis is a sign of extra-articular disease and predicts radiographic progression of joint destruction over 5 years.
    Nyhäll-Wåhlin BM, Turesson C, Jacobsson LT, Nilsson JÅ, Forslind K, Albertsson K, Rönnelid J, Petersson IF.
    Scand J Rheumatol; 2011 Mar; 40(2):81-7. PubMed ID: 20919947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.